Aurobindo Pharma

Sector: Healthcare

Followers

0
0
7
7
.
3
3
3
3
3
3
,
1
1
-8.40 (-0.63%)

As on 02 Apr, 2026 | 15:59

Open Trading A/c
Day Range
1,266.10
1,338.90
LH
52 Week Range
1,010.00
1,359.90
LH
Volume
* i
Bid / Ask
1,870,240.00
1,333.70 / 79.00

Aurobindo Pharma Announcements

Submission of update on solar power purchase agreement and acquisition of 26% stake in Swarnaakshu Solar Power Private Limited.

30 Mar, 2026 | 05:36pm • Source: BSE

Submission of Postal Ballot Results and Scrutinizers Report

30 Mar, 2026 | 12:05pm • Source: BSE

Intimation of entry into marketing and distribution agreement for Biosimilars in EU territories by Curateq Biologics Private Limited, a wholly owned subsidiary of the Company.

25 Mar, 2026 | 04:53pm • Source: BSE

Intimation of closure of Trading Window

23 Mar, 2026 | 05:44pm • Source: BSE

Intimation of classification of Unit-V of Apitoria Pharma Private Limited , a wholly owned subsidiary of the Company as VAI by the US FDA.

20 Mar, 2026 | 09:57am • Source: BSE

Intimation of order received from GST authorities.

13 Mar, 2026 | 12:50pm • Source: BSE

Aurobindo Pharma Limited has informed the Exchange about General Updates

12 Mar, 2026 | 11:01am • Source: NSE

Intimation of classification of Unit-IV of APL Healthcare Limited, a wholly owned subsidiary of the Company as VAI by the US FDA.

12 Mar, 2026 | 09:44am • Source: BSE

Intimation of plant visit by a group of investors on 17.03.2026.

11 Mar, 2026 | 01:14pm • Source: BSE

Intimation of plant visit by investor group on 16.03.2026.

11 Mar, 2026 | 01:11pm • Source: BSE

Aurobindo Pharma Limited has informed the Exchange about Schedule of meet

09 Mar, 2026 | 02:55pm • Source: NSE

Intimation of investor meet to be held on 13.03.2026.

09 Mar, 2026 | 02:40pm • Source: BSE

Aurobindo Pharma Limited has informed the Exchange regarding a press release dated March 04, 2026, titled "Eugia Pharma announces launch of Pomalidomide Capsules in the...

04 Mar, 2026 | 03:49pm • Source: NSE

Submission of press release on launch of Pomalidomide Capsules 1 mg, 2 mg, 3 mg and 4 mg in the US market by Eugia Pharma...

04 Mar, 2026 | 12:08pm • Source: BSE

Intimation of investor meet.

02 Mar, 2026 | 12:19pm • Source: BSE

Submission of press release that Eugia Pharma received USFDA approval for Everolimus Tablets

26 Feb, 2026 | 11:51am • Source: BSE

Aurobindo Pharma Limited has informed the Exchange about Copy of Newspaper Publication

25 Feb, 2026 | 12:10pm • Source: NSE

Submission of Notice published in news papers for attention of shareholders about postal ballot notice and remote e-voting

25 Feb, 2026 | 11:59am • Source: BSE

Intimation of incorporation of a wholly owned subsidiary company in India

24 Feb, 2026 | 04:33pm • Source: BSE